Compass Operating Income from 2010 to 2024

CMPX Stock

USD 1.56 0.05 3.31%

Compass Therapeutics Operating Income yearly trend continues to be fairly stable with very little volatility. Operating Income will likely drop to about -52.9 M in 2024. Operating Income is earnings before interest and taxes (EBIT), representing the amount of profit Compass Therapeutics generates from its operations. View All Fundamentals

Operating Income

First Reported

2019-06-30

Previous Quarter

-12.8 M

Current Value

-15 M

Quarterly Volatility

10.5 M

Covid

Check Compass Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Compass Therapeutics' main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 8.3 M or Interest Income of 8.3 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.4. Compass financial statements analysis is a perfect complement when working with Compass Therapeutics Valuation or Volatility modules.

Check out the analysis of Compass Therapeutics Correlation against competitors.

For more information on how to buy Compass Stock please use our How to Invest in Compass Therapeutics guide.

Latest Compass Therapeutics' Operating Income Growth Pattern

Below is the plot of the Operating Income of Compass Therapeutics over the last few years. Operating Income is the amount of profit realized from Compass Therapeutics operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Compass Therapeutics is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. Compass Therapeutics' Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Compass Therapeutics' overall financial position and show how it may be relating to other accounts over time.

Operating Income

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Operating Income

Timeline

Compass Operating Income Regression Statistics

	Arithmetic Mean	(42,230,210)
	Coefficient Of Variation	(29.45)
	Mean Deviation	7,791,403
	Median	(38,312,000)
	Standard Deviation	12,435,891
	Sample Variance	154.7T
	Range	54.1M
	R-Value	(0.42)
	Mean Square Error	137.5T
	R-Squared	0.17
	Significance	0.12
	Slope	(1,161,661)
	Total Sum of Squares	2165.1T

Compass Operating Income History

	2024	-52.9 M
	2023	-50.4 M
	2022	-41.7 M
	2021	-81.9 M
	2020	-27.8 M
	2019	-34.1 M

Other Fundumenentals of Compass Therapeutics

Non Operating Income Net Other

Compass Therapeutics Operating Income component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Total Liab	Net Invested Capital	Short Long Term Debt	Total Current Assets	Capital Stock	Net Working Capital	Short Term Debt	Common Stock	Property Plant Equipment	Long Term Debt Total	Capital Surpluse	Net Receivables
Total Assets		0.9	0.87	0.58	-0.27	-0.85	0.67	-0.75	-0.76	0.9	0.71	1.0	-0.79	1.0	-0.83	-0.79	-0.43	-0.37	0.93	-0.37
Total Stockholder Equity	0.9		0.99	0.75	-0.21	-0.96	0.53	-0.95	-0.96	1.0	0.87	0.91	-0.96	0.9	-0.64	-0.96	-0.67	-0.57	0.91	-0.57
Net Tangible Assets	0.87	0.99		0.73	-0.14	-0.98	0.57	-0.94	-0.95	0.99	0.86	0.88	-0.94	0.88	-0.65	-0.94	-0.71	-0.67	0.93	-0.67
Current Deferred Revenue	0.58	0.75	0.73		-0.05	-0.79	0.22	-0.87	-0.83	0.75	0.96	0.59	-0.72	0.59	-0.18	-0.72	-0.7	-0.3	0.71	-0.3
Net Debt	-0.27	-0.21	-0.14	-0.05		0.05	0.34	0.16	0.19	-0.21	-0.12	-0.26	0.25	-0.27	0.3	0.25	-0.5	-0.27	-0.09	-0.27
Retained Earnings	-0.85	-0.96	-0.98	-0.79	0.05		-0.58	0.92	0.92	-0.96	-0.88	-0.86	0.88	-0.86	0.65	0.88	0.73	0.7	-0.95	0.7
Accounts Payable	0.67	0.53	0.57	0.22	0.34	-0.58		-0.36	-0.39	0.53	0.38	0.68	-0.44	0.69	-0.6	-0.44	-0.5	-0.42	0.73	-0.42
Long Term Debt	-0.75	-0.95	-0.94	-0.87	0.16	0.92	-0.36		0.99	-0.95	-0.95	-0.76	0.96	-0.75	0.39	0.96	0.76	0.53	-0.82	0.53
Total Liab	-0.76	-0.96	-0.95	-0.83	0.19	0.92	-0.39	0.99		-0.96	-0.93	-0.77	0.98	-0.77	0.42	0.98	0.75	0.54	-0.82	0.54
Net Invested Capital	0.9	1.0	0.99	0.75	-0.21	-0.96	0.53	-0.95	-0.96		0.87	0.91	-0.96	0.9	-0.63	-0.96	-0.68	-0.57	0.91	-0.57
Short Long Term Debt	0.71	0.87	0.86	0.96	-0.12	-0.88	0.38	-0.95	-0.93	0.87		0.72	-0.87	0.72	-0.31	-0.87	-0.74	-0.39	0.82	-0.39
Total Current Assets	1.0	0.91	0.88	0.59	-0.26	-0.86	0.68	-0.76	-0.77	0.91	0.72		-0.8	1.0	-0.82	-0.8	-0.46	-0.38	0.94	-0.38
Capital Stock	-0.79	-0.96	-0.94	-0.72	0.25	0.88	-0.44	0.96	0.98	-0.96	-0.87	-0.8		-0.8	0.46	1.0	0.69	0.51	-0.8	0.51
Net Working Capital	1.0	0.9	0.88	0.59	-0.27	-0.86	0.69	-0.75	-0.77	0.9	0.72	1.0	-0.8		-0.83	-0.8	-0.45	-0.38	0.94	-0.38
Short Term Debt	-0.83	-0.64	-0.65	-0.18	0.3	0.65	-0.6	0.39	0.42	-0.63	-0.31	-0.82	0.46	-0.83		0.46	0.07	0.48	-0.77	0.48
Common Stock	-0.79	-0.96	-0.94	-0.72	0.25	0.88	-0.44	0.96	0.98	-0.96	-0.87	-0.8	1.0	-0.8	0.46		0.69	0.51	-0.8	0.51
Property Plant Equipment	-0.43	-0.67	-0.71	-0.7	-0.5	0.73	-0.5	0.76	0.75	-0.68	-0.74	-0.46	0.69	-0.45	0.07	0.69		0.59	-0.6	0.59
Long Term Debt Total	-0.37	-0.57	-0.67	-0.3	-0.27	0.7	-0.42	0.53	0.54	-0.57	-0.39	-0.38	0.51	-0.38	0.48	0.51	0.59		-0.56	1.0
Capital Surpluse	0.93	0.91	0.93	0.71	-0.09	-0.95	0.73	-0.82	-0.82	0.91	0.82	0.94	-0.8	0.94	-0.77	-0.8	-0.6	-0.56		-0.56
Net Receivables	-0.37	-0.57	-0.67	-0.3	-0.27	0.7	-0.42	0.53	0.54	-0.57	-0.39	-0.38	0.51	-0.38	0.48	0.51	0.59	1.0	-0.56

Click cells to compare fundamentals

About Compass Therapeutics Financial Statements

Compass Therapeutics investors use historical fundamental indicators, such as Compass Therapeutics' Operating Income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Compass Therapeutics. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Operating Income	-50.4 M	-52.9 M
Non Operating Income Net Other	2.8 M	2.9 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

Additional Tools for Compass Stock Analysis

When running Compass Therapeutics' price analysis, check to measure Compass Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Compass Therapeutics is operating at the current time. Most of Compass Therapeutics' value examination focuses on studying past and present price action to predict the probability of Compass Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Compass Therapeutics' price. Additionally, you may evaluate how the addition of Compass Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Compass Operating Income from 2010 to 2024

Latest Compass Therapeutics' Operating Income Growth Pattern

Compass Operating Income Regression Statistics

Compass Operating Income History

Other Fundumenentals of Compass Therapeutics

Compass Therapeutics Operating Income component correlations

About Compass Therapeutics Financial Statements

Also Currently Popular

Additional Tools for Compass Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY